AM Pharma
NetherlandsEntry
2019
Hold
7yr
Status
Active
Who owns AM Pharma?
AM Pharma is currently owned by Andera Partners through BioDiscovery 5 (2017 vintage), since 2019. Across its history, AM Pharma has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Andera PartnersBioDiscovery 5 · 2017 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2011 · present
Ysios Capital PartnersActive
2011 · present(15yr) · Ysios BioFund I · 2008 · Life Sciences VC
EurazeoActive
2016 · present(10yr) · Kurma Biofund III · 2017 · Healthcare
Andera PartnersActive
2019 · present(7yr) · BioDiscovery 5 · 2017 · VC
More from BioDiscovery 5
Other portfolio companies in the same fund.
France
Belgium
Switzerland
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track AM Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy AM Pharma?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on AM Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue